Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,677,590 | 3,927,521 | 921,214 | 1,954,372 | 4,000,360 |
| Marketable Securities | 1,168,723 | 627,651 | 508,346 | N/A | 265,016 |
| Receivables | 5,622,687 | 4,899,148 | 5,497,946 | 4,930,589 | 4,457,858 |
| Inventories | 2,997,381 | 3,051,046 | 3,023,651 | 2,839,715 | 2,842,485 |
| Other current assets | -1 | 4 | 0 | 357,264 | 1 |
| TOTAL | $14,466,380 | $12,505,370 | $9,951,157 | $10,081,940 | $11,565,720 |
| Non-Current Assets | |||||
| PPE Net | 8,384,072 | 8,441,520 | 8,336,641 | 7,701,211 | 7,838,225 |
| Investments And Advances | 281,991 | 298,102 | 283,513 | 252,474 | 256,381 |
| Intangibles | 3,255,424 | 3,286,091 | 3,299,870 | 3,164,652 | 1,478,155 |
| Other Non-Current Assets | 1,221,853 | 1,096,117 | 1,047,646 | 1,001,773 | 833,199 |
| TOTAL | $13,143,340 | $13,121,830 | $12,967,670 | $12,120,110 | $10,405,960 |
| Total Assets | $27,609,720 | $25,627,200 | $22,918,830 | $22,202,050 | $21,971,680 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 214,110 | 210,892 | 1,106,008 | 1,142,719 | 230,476 |
| Accounts payable and accrued liabilities | 1,407,892 | 1,234,554 | 1,102,280 | 875,844 | 961,311 |
| Other current liabilities | 11,436,170 | 9,884,696 | 9,054,258 | 8,147,789 | 9,159,065 |
| TOTAL | $14,008,820 | $11,800,560 | $11,733,450 | $10,765,820 | $11,138,840 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,966,323 | 2,020,252 | 459,067 | 443,820 | 413,852 |
| Other Non-Current Liabilities | 888,635 | 884,580 | 925,916 | 907,710 | 910,443 |
| TOTAL | $3,115,538 | $3,199,530 | $1,703,185 | $1,734,837 | $1,479,882 |
| Total Liabilities | $17,124,360 | $15,000,090 | $13,436,630 | $12,500,660 | $12,618,720 |
| Shareholders' Equity | |||||
| Common Shares | 73,273 | 74,890 | 76,187 | 72,004 | 73,790 |
| Retained earnings | 10,771,160 | 10,889,720 | 9,774,144 | 9,770,177 | 9,396,450 |
| Other shareholders' equity | -358,073 | -337,500 | -367,130 | -139,791 | -116,279 |
| TOTAL | $10,485,360 | $10,627,110 | $9,482,201 | $9,701,390 | $9,352,961 |
| Total Liabilities And Equity | $27,609,720 | $25,627,200 | $22,918,831 | $22,202,050 | $21,971,681 |